2025-08-14 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
1,849,590 |
1,370,938 |
|
|
|
2025-08-14 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,745,000 |
1,625,000 |
|
|
|
2025-08-14 |
13G
|
CABA / Cabaletta Bio, Inc.
|
|
0 |
5,000,000 |
|
|
|
2025-08-14 |
13G/A
|
BIOA / BioAge Labs, Inc.
|
|
2,629,529 |
2,140,605 |
|
|
|
2025-05-19 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
0 |
1,849,590 |
|
|
|
2025-05-19 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
1,837,739 |
0 |
|
|
|
2025-05-15 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
1,394,336 |
0 |
|
|
|
2025-05-15 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,693,219 |
1,745,000 |
|
|
|
2025-05-15 |
13G
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
3,381,277 |
|
|
|
2025-02-14 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
870,000 |
1,693,219 |
|
|
|
2025-02-14 |
13G
|
KALA / KALA BIO, Inc.
|
|
|
609,027 |
|
|
|
2025-02-14 |
13G
|
BIOA / BioAge Labs, Inc.
|
|
|
2,629,529 |
|
|
|
2024-11-14 |
13G/A
|
RAPP / Rapport Therapeutics, Inc.
|
|
2,940,283 |
2,940,921 |
|
|
|
2024-11-14 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
6,038,235 |
8,325,000 |
|
|
|
2024-11-14 |
13G/A
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
2,141,506 |
2,790,462 |
|
|
|
2024-11-14 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
2,025,000 |
2,375,000 |
|
|
|
2024-11-14 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
633,345 |
870,000 |
|
|
|
2024-11-14 |
13G/A
|
VTYX / Ventyx Biosciences, Inc.
|
|
3,670,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
2,221,422 |
500,000 |
|
|
|
2024-11-14 |
13G/A
|
TCRX / TScan Therapeutics, Inc.
|
|
2,500,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
3,250,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
746,180 |
107,344 |
|
|
|
2024-11-14 |
13G/A
|
IMRX / Immuneering Corporation
|
|
1,700,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
KRRO / Korro Bio, Inc.
|
|
529,170 |
265,826 |
|
|
|
2024-11-14 |
13G/A
|
ALXO / ALX Oncology Holdings Inc.
|
|
3,142,079 |
0 |
|
|
|
2024-11-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
5,750,000 |
0 |
|
|
|
2024-11-06 |
13G/A
|
DRUG / Bright Minds Biosciences Inc.
|
|
850,000 |
1,059,331 |
|
|
|
2024-10-22 |
13G
|
DRUG / Bright Minds Biosciences Inc.
|
|
|
850,000 |
|
|
|
2024-10-16 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
1,837,739 |
|
|
|
2024-10-11 |
13G
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
1,895,717 |
|
|
|
2024-06-20 |
13G
|
RAPP / Rapport Therapeutics, Inc.
|
|
|
2,940,283 |
|
|
|
2024-05-13 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
5,750,000 |
|
|
|
2024-04-29 |
13G
|
TCRX / TScan Therapeutics, Inc.
|
|
|
2,500,000 |
|
|
|
2024-04-15 |
13G/A
|
IMRX / Immuneering Corporation
|
|
4,204,364 |
1,700,000 |
|
|
|
2024-03-21 |
13G
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
3,670,000 |
|
|
|
2024-03-18 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
0 |
2,025,000 |
|
|
|
2024-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
2,850,000 |
2,550,000 |
|
|
|
2024-02-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
2,082,000 |
2,456,800 |
|
|
|
2024-02-14 |
13G/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
1,957,132 |
1,211,696 |
|
|
|
2024-02-14 |
13G
|
NGNE / Neurogene Inc.
|
|
|
746,180 |
|
|
|
2024-02-14 |
13G/A
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
2,800,000 |
3,250,000 |
|
|
|
2024-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,736,422 |
2,221,422 |
|
|
|
2024-02-14 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
633,345 |
|
|
|
2024-02-14 |
13G/A
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
1,801,947 |
2,141,506 |
|
|
|
2024-02-14 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
|
11,231,000 |
|
|
|
2024-02-14 |
13G/A
|
KRRO / Korro Bio, Inc.
|
|
679,170 |
529,170 |
|
|
|
2024-02-14 |
13G/A
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
2,893,717 |
0 |
|
|
|
2024-02-14 |
13G/A
|
DSGN / Design Therapeutics, Inc.
|
|
5,150,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
1,391,663 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
1,952,032 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
1,971,739 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
2,550,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,650,000 |
0 |
|
|
|
2024-01-30 |
13D/A
|
ERAS / Erasca, Inc.
|
|
10,893,107 |
0 |
|
|
|
2023-12-14 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
6,038,235 |
|
|
|
2023-11-16 |
13G
|
KRRO / Korro Bio, Inc.
|
|
|
679,170 |
|
|
|
2023-11-13 |
13G
|
VYNE / VYNE Therapeutics Inc.
|
|
|
1,394,336 |
|
|
|
2023-11-06 |
13G
|
HARP / Harpoon Therapeutics, Inc.
|
|
|
1,678,619 |
|
|
|
2023-10-23 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
2,850,000 |
|
|
|
2023-10-13 |
13G
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
3,142,079 |
|
|
|
2023-10-10 |
13G
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
2,800,000 |
|
|
|
2023-04-24 |
13G/A
|
IMRX / Immuneering Corporation
|
|
2,286,181 |
4,204,364 |
|
|
|
2023-03-13 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
16,354,702 |
52,500,000 |
|
|
|
2023-02-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
1,983,168 |
1,952,032 |
|
|
|
2023-02-14 |
13G/A
|
DSGN / Design Therapeutics, Inc.
|
|
5,440,451 |
5,150,000 |
|
|
|
2023-02-14 |
13G/A
|
US39536G1058 / GREENLIGHT BIOSCIENCES HOLDINGS PBC A
|
|
9,479,058 |
9,188,659 |
|
|
|
2023-02-14 |
13G/A
|
IMRX / Immuneering Corporation
|
|
2,252,628 |
2,286,181 |
|
|
|
2023-02-14 |
13G/A
|
BCAB / BioAtla, Inc.
|
|
2,038,215 |
3,680,365 |
|
|
|
2023-02-14 |
13G/A
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
3,002,200 |
2,893,717 |
|
|
|
2023-02-14 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
17,266,144 |
16,354,702 |
|
|
|
2023-02-14 |
13G/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
1,830,691 |
1,957,132 |
|
|
|
2023-02-14 |
13G/A
|
ALT / Altimmune, Inc.
|
|
2,650,000 |
2,600,000 |
|
|
|
2023-02-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
2,169,871 |
2,082,000 |
|
|
|
2023-02-14 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
2,200,000 |
2,075,000 |
|
|
|
2023-02-14 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
2,000,000 |
1,971,739 |
|
|
|
2023-02-14 |
13G/A
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
1,381,932 |
1,801,947 |
|
|
|
2023-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
1,436,322 |
1,100,000 |
|
|
|
2023-02-14 |
13G/A
|
VECT / VectivBio Holding AG
|
|
2,216,763 |
2,536,617 |
|
|
|
2023-02-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
700,000 |
1,650,000 |
|
|
|
2023-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,403,331 |
1,736,422 |
|
|
|
2023-02-14 |
13G/A
|
RXDX / Prometheus Biosciences Inc
|
|
2,224,847 |
2,090,000 |
|
|
|
2023-02-14 |
13G/A
|
TNGX / Tango Therapeutics, Inc.
|
|
4,899,184 |
4,116,949 |
|
|
|
2023-02-14 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
1,428,598 |
1,391,663 |
|
|
|
2022-12-29 |
13G
|
ETNB / 89bio, Inc.
|
|
|
2,550,000 |
|
|
|
2022-12-27 |
13G
|
RNA / Avidity Biosciences, Inc.
|
|
2,012,115 |
2,762,115 |
|
|
|
2022-12-21 |
13D/A
|
ERAS / Erasca, Inc.
|
|
10,505,553 |
10,893,107 |
|
|
|
2022-10-31 |
13G
|
CABA / Cabaletta Bio, Inc.
|
|
1,154,424 |
2,000,000 |
|
|
|
2022-09-02 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
700,000 |
|
|
|
2022-08-29 |
13G
|
ACLX / Arcellx, Inc.
|
|
|
2,200,000 |
|
|
|
2022-07-07 |
13G
|
ALT / Altimmune, Inc.
|
|
|
2,650,000 |
|
|
|
2022-06-17 |
13G
|
VECT / VectivBio Holding AG
|
|
|
2,216,763 |
|
|
|
2022-06-07 |
13G
|
RXDX / Prometheus Biosciences Inc
|
|
1,848,022 |
2,224,847 |
|
|
|
2022-02-14 |
13G
|
US39536G1058 / GREENLIGHT BIOSCIENCES HOLDINGS PBC A
|
|
|
9,479,058 |
|
|
|
2022-02-14 |
13G
|
TNGX / Tango Therapeutics, Inc.
|
|
|
4,899,184 |
|
|
|
2022-02-14 |
13G/A
|
RXDX / Prometheus Biosciences Inc
|
|
|
1,848,022 |
|
|
|
2022-02-14 |
13G/A
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
1,339,631 |
1,381,932 |
|
|
|
2022-02-14 |
13G/A
|
GLTO / Galecto, Inc.
|
|
2,150,732 |
1,020,240 |
|
|
|
2022-02-14 |
13G/A
|
FMTX / Forma Therapeutics Holdings Inc
|
|
4,460,000 |
4,639,998 |
|
|
|
2022-02-14 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
2,490,065 |
0 |
|
|
|
2022-02-14 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
1,904,424 |
1,154,424 |
|
|
|
2022-02-14 |
13G/A
|
RVMD / Revolution Medicines, Inc.
|
|
3,675,000 |
2,431,852 |
|
|
|
2022-02-14 |
13G/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
2,030,691 |
1,830,691 |
|
|
|
2022-02-14 |
13G/A
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
3,193,974 |
3,002,200 |
|
|
|
2022-02-14 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
17,404,702 |
17,266,144 |
|
|
|
2022-02-14 |
13G/A
|
BCAB / BioAtla, Inc.
|
|
2,292,060 |
2,038,215 |
|
|
|
2022-02-14 |
13G/A
|
DSGN / Design Therapeutics, Inc.
|
|
5,114,844 |
5,440,451 |
|
|
|
2022-02-14 |
13G/A
|
RNA / Avidity Biosciences, Inc.
|
|
2,464,547 |
2,012,115 |
|
|
|
2022-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
459,144 |
1,436,322 |
|
|
|
2022-02-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
6,411,355 |
1,679,442 |
|
|
|
2022-02-14 |
13G/A
|
OTIC / Otonomy Inc
|
|
2,600,000 |
0 |
|
|
|
2022-02-14 |
13G
|
TPTX / Turning Point Therapeutics Inc
|
|
2,392,297 |
3,025,000 |
|
|
|
2022-02-14 |
13G/A
|
OMER / Omeros Corporation
|
|
5,000,000 |
0 |
|
|
|
2022-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,714,269 |
1,403,331 |
|
|
|
2022-02-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
3,195,544 |
2,169,871 |
|
|
|
2022-02-14 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
1,428,598 |
|
|
|
2021-08-13 |
13G
|
IMRX / Immuneering Corporation
|
|
|
2,252,628 |
|
|
|
2021-08-10 |
13D/A
|
ERAS / Erasca, Inc.
|
|
10,505,553 |
10,505,553 |
|
|
|
2021-07-30 |
13D
|
ERAS / Erasca, Inc.
|
|
|
10,505,553 |
|
|
|
2021-07-12 |
13G
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
2,030,691 |
|
|
|
2021-07-09 |
13G
|
ELEV / Elevation Oncology, Inc.
|
|
|
1,983,168 |
|
|
|
2021-07-08 |
13G
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
3,193,974 |
|
|
|
2021-07-02 |
13G
|
AMAM / Ambrx Biopharma Inc.
|
|
|
17,404,702 |
|
|
|
2021-05-19 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
2,495,066 |
3,675,000 |
|
|
|
2021-04-09 |
13G
|
DSGN / Design Therapeutics, Inc.
|
|
0 |
5,114,844 |
|
|
|
2021-03-26 |
13G
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
|
1,339,631 |
|
|
|
2021-02-16 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
3,150,000 |
1,200,000 |
|
|
|
2021-02-16 |
13G/A
|
US74257L1089 / Principia Biopharma Inc.
|
|
1,990,922 |
0 |
|
|
|
2021-02-16 |
13G/A
|
TPTX / Turning Point Therapeutics Inc
|
|
3,396,650 |
2,392,297 |
|
|
|
2021-02-16 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
|
6,411,355 |
|
|
|
2021-02-16 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,964,268 |
1,714,269 |
|
|
|
2021-02-16 |
13G/A
|
GLTO / Galecto, Inc.
|
|
2,281,220 |
2,150,732 |
|
|
|
2021-02-16 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
3,270,544 |
3,195,544 |
|
|
|
2021-02-16 |
13G/A
|
BCAB / BioAtla, Inc.
|
|
2,292,060 |
2,292,060 |
|
|
|
2021-02-16 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
1,788,663 |
1,437,807 |
|
|
|
2021-02-16 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
2,119,133 |
1,904,424 |
|
|
|
2021-02-16 |
13G/A
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
2,300,000 |
0 |
|
|
|
2021-02-16 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
1,144,537 |
0 |
|
|
|
2021-02-16 |
13G/A
|
RNA / Avidity Biosciences, Inc.
|
|
2,514,545 |
2,464,547 |
|
|
|
2021-02-16 |
13G/A
|
OMER / Omeros Corporation
|
|
3,000,000 |
5,000,000 |
|
|
|
2021-02-16 |
13G/A
|
FMTX / Forma Therapeutics Holdings Inc
|
|
3,379,370 |
4,460,000 |
|
|
|
2021-02-16 |
13G/A
|
AVEO / AVEO Pharmaceuticals Inc
|
|
1,350,000 |
0 |
|
|
|
2021-02-16 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
2,490,068 |
2,490,065 |
|
|
|
2021-02-16 |
13G/A
|
OTIC / Otonomy Inc
|
|
2,500,000 |
2,600,000 |
|
|
|
2021-02-16 |
13G/A
|
AGEN / Agenus Inc.
|
|
11,500,000 |
7,000,000 |
|
|
|
2021-02-16 |
13G/A
|
RVMD / Revolution Medicines, Inc.
|
|
3,245,177 |
2,495,066 |
|
|
|
2021-01-19 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
459,144 |
|
|
|
2021-01-19 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
459,144 |
|
|
|
2021-01-04 |
13G
|
88907J107 / Novus Therapeutics, Inc.
|
|
|
1,415,500 |
|
|
|
2020-12-28 |
13G
|
BCAB / BioAtla, Inc.
|
|
|
2,292,060 |
|
|
|
2020-11-23 |
13G
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
3,270,544 |
|
|
|
2020-11-12 |
13G
|
GLTO / Galecto, Inc.
|
|
|
2,281,220 |
|
|
|
2020-10-30 |
13G
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
1,964,268 |
|
|
|
2020-10-16 |
13G
|
CCCC / C4 Therapeutics, Inc.
|
|
|
2,490,068 |
|
|
|
2020-07-20 |
13G
|
OTIC / Otonomy Inc
|
|
|
2,500,000 |
|
|
|
2020-07-06 |
13G
|
FMTX / Forma Therapeutics Holdings Inc
|
|
|
3,379,370 |
|
|
|
2020-06-29 |
13G
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
1,350,000 |
|
|
|
2020-06-26 |
13G
|
RNA / Avidity Biosciences, Inc.
|
|
|
2,514,545 |
|
|
|
2020-05-04 |
13G
|
OMER / Omeros Corporation
|
|
900,000 |
3,000,000 |
|
|
|
2020-04-27 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
1,144,537 |
|
|
|
2020-03-20 |
13G
|
AGEN / Agenus Inc.
|
|
|
11,500,000 |
|
|
|
2020-02-24 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
|
3,245,177 |
|
|
|
2020-02-14 |
13G/A
|
US74257L1089 / Principia Biopharma Inc.
|
|
1,474,362 |
1,990,922 |
|
|
|
2020-02-14 |
13G/A
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
1,747,776 |
2,300,000 |
|
|
|
2020-02-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
2,150,000 |
1,782,392 |
|
|
|
2020-02-14 |
13G/A
|
TPTX / Turning Point Therapeutics Inc
|
|
3,122,367 |
3,396,650 |
|
|
|
2020-02-14 |
13G/A
|
IFRX / InflaRx N.V.
|
|
2,670,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
AVRO / AVROBIO, Inc.
|
|
1,357,784 |
317,579 |
|
|
|
2020-02-14 |
13G/A
|
KZR / Kezar Life Sciences, Inc.
|
|
1,422,911 |
0 |
|
|
|
2020-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
4,762,772 |
3,500,000 |
|
|
|
2020-02-14 |
13G/A
|
IMVT / Immunovant, Inc.
|
|
|
1,080,000 |
|
|
|
2020-02-14 |
13G/A
|
NXTC / NextCure, Inc.
|
|
1,200,000 |
1,000,000 |
|
|
|
2020-02-14 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
2,119,132 |
2,119,133 |
|
|
|
2020-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,481,471 |
0 |
|
|
|
2020-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
1,869,680 |
1,788,663 |
|
|
|
2020-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
940,387 |
488,565 |
|
|
|
2020-02-14 |
13G/A
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
4,502,498 |
2,700,000 |
|
|
|
2020-01-10 |
13G
|
CCXI / ChemoCentryx Inc
|
|
3,300,000 |
3,150,000 |
|
|
|
2019-12-16 |
13G
|
CCXI / ChemoCentryx Inc
|
|
|
3,300,000 |
|
|
|
2019-11-18 |
13G
|
NXTC / NextCure, Inc.
|
|
|
1,200,000 |
|
|
|
2019-11-18 |
13G
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
1,271,687 |
1,747,776 |
|
|
|
2019-11-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,751,699 |
2,150,000 |
|
|
|
2019-11-07 |
13G
|
CABA / Cabaletta Bio, Inc.
|
|
|
2,119,132 |
|
|
|
2019-07-01 |
13G
|
STOK / Stoke Therapeutics, Inc.
|
|
|
1,869,680 |
|
|
|
2019-05-20 |
13G
|
IMVT / Immunovant, Inc.
|
|
|
1,080,000 |
|
|
|
2019-05-20 |
13G
|
IMVT / Immunovant, Inc.
|
|
|
1,080,000 |
|
|
|
2019-05-03 |
13G
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
1,300,000 |
|
|
|
2019-04-25 |
13G
|
TPTX / Turning Point Therapeutics Inc
|
|
|
3,122,367 |
|
|
|
2019-04-22 |
13G/A
|
IFRX / InflaRx N.V.
|
|
1,475,140 |
2,670,000 |
|
|
|
2019-04-22 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
940,387 |
|
|
|
2019-02-14 |
13G/A
|
AVRO / AVROBIO, Inc.
|
|
1,507,781 |
1,357,784 |
|
|
|
2019-02-14 |
13G/A
|
IFRX / InflaRx N.V.
|
|
1,438,207 |
1,475,140 |
|
|
|
2019-02-14 |
13G/A
|
GEMP / Gemphire Therapeutics Inc.
|
|
839,599 |
39,599 |
|
|
|
2019-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
4,587,683 |
4,762,772 |
|
|
|
2019-02-14 |
13G/A
|
TRIL / Trillium Therapeutics Inc
|
|
600,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
IL0011177958 / Intec Pharma Ltd
|
|
809,804 |
0 |
|
|
|
2019-02-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,430,600 |
1,751,699 |
|
|
|
2019-02-14 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
1,940,880 |
0 |
|
|
|
2019-02-14 |
13G/A
|
US74257L1089 / Principia Biopharma Inc.
|
|
1,486,898 |
1,474,362 |
|
|
|
2019-02-14 |
13G/A
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
3,768,756 |
4,502,498 |
|
|
|
2019-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
6,668,203 |
6,023,841 |
|
|
|
2019-02-14 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
3,300,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,656,669 |
3,481,471 |
|
|
|
2019-02-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,254,185 |
1,105,557 |
|
|
|
2019-02-14 |
13G/A
|
KZR / Kezar Life Sciences, Inc.
|
|
1,572,909 |
1,422,911 |
|
|
|
2019-02-14 |
13G/A
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
1,471,687 |
1,271,687 |
|
|
|
2019-02-14 |
13G/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
830,999 |
831,000 |
|
|
|
2018-11-09 |
13G
|
AXNX / Axonics, Inc.
|
|
|
1,285,827 |
|
|
|
2018-09-24 |
13G
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
1,486,898 |
|
|
|
2018-07-30 |
13G
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
1,471,687 |
|
|
|
2018-07-02 |
13G
|
AVRO / AVROBIO, Inc.
|
|
|
1,507,781 |
|
|
|
2018-07-02 |
13G
|
KZR / Kezar Life Sciences, Inc.
|
|
|
1,572,909 |
|
|
|
2018-06-04 |
13G
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
830,999 |
|
|
|
2018-02-14 |
13G
|
IFRX / InflaRx N.V.
|
|
|
1,438,207 |
|
|
|
2018-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
2,940,000 |
4,587,683 |
|
|
|
2018-02-14 |
13G/A
|
GEMP / Gemphire Therapeutics Inc.
|
|
900,000 |
839,599 |
|
|
|
2018-02-14 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
2,500,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
480,501 |
0 |
|
|
|
2018-02-14 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
2,652,436 |
607,903 |
|
|
|
2018-02-14 |
13G/A
|
APTO / Aptose Biosciences Inc.
|
|
990,579 |
0 |
|
|
|
2018-02-14 |
13G/A
|
TGXSF / Tigenix Sa
|
|
14,472,631 |
9,972,386 |
|
|
|
2018-02-14 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
3,000,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
2,333,333 |
1,940,880 |
|
|
|
2018-02-14 |
13G/A
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
3,768,756 |
|
|
|
2018-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
4,188,212 |
6,668,203 |
|
|
|
2018-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
2,307,898 |
3,656,669 |
|
|
|
2018-02-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,168,394 |
1,254,185 |
|
|
|
2018-02-14 |
13G/A
|
OMER / Omeros Corporation
|
|
975,000 |
900,000 |
|
|
|
2018-01-22 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
1,430,600 |
|
|
|
2017-12-18 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
3,804,027 |
3,300,000 |
|
|
|
2017-11-21 |
13G
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
3,473,925 |
|
|
|
2017-10-20 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
|
1,168,394 |
|
|
|
2017-09-11 |
13G
|
451731103 / Ignyta, Inc.
|
|
|
3,000,000 |
|
|
|
2017-06-05 |
13G
|
TRIL / Trillium Therapeutics Inc
|
|
|
600,000 |
|
|
|
2017-04-21 |
13G
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
2,307,898 |
|
|
|
2017-02-14 |
13G/A
|
APTO / Aptose Biosciences Inc.
|
|
|
990,579 |
|
|
|
2017-02-14 |
13G/A
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2017-02-14 |
13G
|
TGXSF / Tigenix Sa
|
|
14,601,663 |
14,472,631 |
|
|
|
2017-02-14 |
13G/A
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
780,501 |
480,501 |
|
|
|
2017-02-14 |
13G/A
|
REPH / Societal CDMO Inc
|
|
|
603,000 |
|
|
|
2017-02-14 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
2,450,882 |
3,804,027 |
|
|
|
2017-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
|
2,940,000 |
|
|
|
2017-02-14 |
13G/A
|
SRNE / Sorrento Therapeutics, Inc.
|
|
|
1,909,000 |
|
|
|
2017-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
1,000,000 |
1,000,000 |
|
|
|
2017-02-14 |
13G/A
|
OMER / Omeros Corporation
|
|
|
975,000 |
|
|
|
2017-02-14 |
13G/A
|
US62857M1053 / MyoKardia, Inc.
|
|
1,605,790 |
1,445,090 |
|
|
|
2017-02-14 |
13G/A
|
IL0011177958 / Intec Pharma Ltd
|
|
|
809,804 |
|
|
|
2017-02-14 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
|
2,652,436 |
|
|
|
2017-02-14 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
2,350,700 |
2,500,000 |
|
|
|
2017-02-14 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
0 |
|
|
|
2017-02-14 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
1,988,208 |
2,333,333 |
|
|
|
2017-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
4,255,576 |
4,188,212 |
|
|
|
2017-02-14 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
106,648 |
|
|
|
2017-02-14 |
13G/A
|
ARDX / Ardelyx, Inc.
|
|
|
2,212,151 |
|
|
|
2017-01-30 |
13G
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
|
780,501 |
|
|
|
2016-12-23 |
13G
|
TGXSF / Tigenix Sa
|
|
|
14,601,663 |
|
|
|
2016-11-07 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
|
2,450,882 |
|
|
|
2016-10-31 |
13G
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
1,000,000 |
|
|
|
2016-10-11 |
13G
|
US62857M1053 / MyoKardia, Inc.
|
|
|
1,605,790 |
|
|
|
2016-09-29 |
13G
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
2,350,700 |
|
|
|
2016-08-15 |
13G
|
GEMP / Gemphire Therapeutics Inc.
|
|
|
900,000 |
|
|
|
2016-08-01 |
13G
|
CFRX / ContraFect Corp
|
|
|
4,255,576 |
|
|
|
2016-06-13 |
13G
|
CLSD / Clearside Biomedical, Inc.
|
|
|
1,988,208 |
|
|
|
2014-09-02 |
13G
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
1,060,000 |
|
|
|
2014-04-14 |
13G
|
APTO / Aptose Biosciences Inc.
|
|
|
13,000,000 |
|
|
|
2014-03-25 |
13G
|
GNVC / GenVec, Inc.
|
|
|
1,329,300 |
|
|
|
2014-03-17 |
13G
|
REPH / Societal CDMO Inc
|
|
|
500,000 |
|
|
|